Data Show Statistically Significant Improvements in Pain, Function and Tendon Structure in Appropriately Dosed Patients TenoMiR to Progress to Phase 3 Study for Lateral Epicondylitis, Making it One of ...
Capricor Therapeutics, Inc. (NASDAQ:CAPR) Q4 2025 Earnings Call Transcript March 12, 2026 Operator: Good afternoon, ladies and gentlemen, and welcome to the Capricor Therapeutics, Inc. fourth quarter ...
Advancing transformation into a diversified biomedical innovation company with a clear path to cash flow positiveOramed strategic transaction ...
Reduced progression of myocardial fibrosis measured by LGE on cardiac MRI (p=0.022)Significant improvement in LVEF versus placebo in patients ...
Capricor Therapeutics (CAPR) upgraded to Buy as FDA accepts HOPE-3 for Deramiocel in DMD cardiomyopathy; PDUFA Aug 22, 2026. Click here to read more.
Advancing transformation into a diversified biomedical innovation company with a clear path to cash flow positive Oramed strategic transaction receives shareholder approval- Lifeward gains new oral ...
I'm the Vice President here on the biotech equity research team at TD Cowen. We're pleased to have here Erick Lucera, the CFO from Dyne, and we're looking forward to hearing all the exciting progress ...
2don MSN
Early signs of deadly meningitis everyone must know - as two die, eleven 'seriously ill' in outbreak
Meningitis can strike quickly - and early symptoms can be easily mistaken for a bad cold, flu or even a hangover. Here, the ...
Powerful winds and extreme weather are knocking out power, damaging property, and fueling wildfires across parts of the ...
Early GO decision reached ahead of Q2'26 guidance based on GO criteria of 20 confirmed responders achieved with less than 40 planned participants completing open-label Part A Key objectives achieved: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results